Oyster Point Pharma, Inc. - common stock (NQ:OYST)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 30, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Oyster Point Pharma, Inc. - common stock

< Previous 1 2 3 Next >

Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7 ↗

February 21, 2024

Goldman Sachs' Hedge Fund Trend Monitor highlights concentration in mega-caps, with optimism in AI and health care.

Via Benzinga

Topics Artificial Intelligence

The 7 Best Crypto and Stocks to Buy as Christmas Gifts This Year ↗

December 21, 2022

These stocks to buy as Christmas gifts provide a number of reasons for investors to rejoice this holiday season.

Via InvestorPlace

The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond ↗

December 18, 2022

These seven hottest healthcare stocks have strong growth catalysts that could send each of them higher over the next few years.

Via InvestorPlace

OYSTER POINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oyster Point Pharma, Inc. - OYST

December 07, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Why Viatris Stock Is Jumping Today ↗

November 07, 2022

Investors are applauding a key step in Viatris' plans to return to growth.

Via The Motley Fool

Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 02, 2022

From Oyster Point Pharma, Inc.

Via GlobeNewswire

Better Dividend Stock: AbbVie or Viatris? ↗

November 26, 2022

These pharmaceutical companies are profitable and offer above-average dividends.

Via The Motley Fool

Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights

November 10, 2022

From Oyster Point Pharma, Inc.

Via GlobeNewswire

OYSTER POINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oyster Point Pharma, Inc. - OYST

November 08, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Oyster Point Pharma, Inc. (Nasdaq - OYST), Benefitfocus, Inc. (Nasdaq - BNFT), Abiomed, Inc. (Nasdaq - ABMD), Atlas Corp. (NYSE - ATCO)

November 08, 2022

From Brodsky & Smith LLC

Via GlobeNewswire

Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25% ↗

November 08, 2022

SVB Leerink raised the price target on Cigna Corporation (NYSE: CI) from $305 to $335. Cigna shares rose 0.7% to close at $324.37 on Monday.

Via Benzinga

Spirit AeroSystems, Oyster Point Pharma, Snap And Other Big Gainers From Monday ↗

November 08, 2022

U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗

November 08, 2022

Upgrades

Via Benzinga

Dow Surges 400 Points; Crude Oil Down 1% ↗

November 07, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 07, 2022

Gainers

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Analyzing Oyster Point Pharma's Short Interest ↗

November 07, 2022

Oyster Point Pharma's (NASDAQ:OYST) short percent of float has fallen 17.95% since its last report. The company recently reported that it has 1.69 million shares sold short, which is 11.93% of all...

Via Benzinga

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

November 07, 2022

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Via Benzinga

Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet ↗

November 07, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.

Via Benzinga

Oyster Point Pharma (NASDAQ: OYST) Enters Into Agreement to be Acquired by Viatris (NASDAQ: VTRS) For $11 Per Share Plus CVR Up to $2.00 Per Share

November 07, 2022

Oyster Point Pharma, Inc. (NASDAQ: OYST) is engaged as a commercial-stage biopharmaceutical company, which is focused on the research, development

Via Spotlight Growth

Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge ↗

November 07, 2022

Via Benzinga

Viatris (VTRS) Stock Pops 17% on Acquisition News ↗

November 07, 2022

One press release with numerous positive catalysts is prompting some VTRS stock traders to load up on the shares today.

Via InvestorPlace

US Stocks Mixed; Dow Rises Over 50 Points ↗

November 07, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.

Via Benzinga

OYST Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Oyster Point Pharma, Inc. Is Fair to Shareholders

November 07, 2022

From Halper Sadeh LLC

Via Business Wire

Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris

November 07, 2022

From Oyster Point Pharma, Inc.

Via GlobeNewswire

Oyster Point Pharma To Report Third Quarter 2022 Financial Results On November 10, 2022

November 02, 2022

Conference Call and Webcast Scheduled for November 10, 2022, 4:30 p.m. ET

From Oyster Point Pharma, Inc.

Via GlobeNewswire

Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 02, 2022

From Oyster Point Pharma, Inc.

Via GlobeNewswire

Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 04, 2022

From Oyster Point Pharma, Inc.

Via GlobeNewswire

10 Short Squeeze Candidates That May Soar: Minerva Neurosciences, FaZe, Getty Images And More ↗

September 26, 2022

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.

Via Benzinga

This Nasal Spray For Eye Disease Stock Is 'Attractive', Has Potential 160% Upside ↗

August 11, 2022

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.